Trinity Legacy Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
6,141
+483
+9% +$211K 0.49% 63
2026
Q1
$2.64M Buy
5,658
+408
+8% +$206K 0.57% 59
2025
Q4
$2.97M Buy
5,250
+71
+1% +$37.8K 0.68% 57
2025
Q3
$2.77M Buy
5,179
+212
+4% +$102K 0.64% 59
2025
Q2
$2.55M Buy
4,967
+53
+1% +$27.7K 0.62% 58
2025
Q1
$2.77M Buy
4,914
+4,064
+478% +$2.25M 0.7% 58
2024
Q4
$444K Hold
850
0.11% 80
2024
Q3
$414K Sell
850
-156
-16% -$72.6K 0.11% 79
2024
Q2
$448K Buy
1,006
+228
+29% +$90.8K 0.13% 77
2024
Q1
$310K Sell
778
-277
-26% -$105K 0.09% 82
2023
Q4
$356K Sell
1,055
-13,804
-93% -$4.11M 0.11% 82
2023
Q3
$4.34M Sell
14,859
-728
-5% -$227K 1.5% 25
2023
Q2
$5.33M Buy
15,587
+2,442
+19% +$739K 1.86% 20
2023
Q1
$3.36M Buy
+13,145
New +$3.24M 1.26% 35

Other funds holding ISRG

Trinity Legacy Partners's ISRG Position: Q2 2026 in Review

Trinity Legacy Partners increased its Intuitive Surgical (ISRG) stake by 8.5% in Q2 2026, buying an estimated $211K and bringing the position to 6,141 shares worth $2.47M. The position accounts for 0.49% of the portfolio, ranked #63.

Trinity Legacy Partners first reported a position in ISRG in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.33M in Q2 2023. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Trinity Legacy Partners held 6,141 shares of Intuitive Surgical worth $2.47M as of Q2 2026.
  • Trinity Legacy Partners bought 483 Intuitive Surgical shares in Q2 2026, an estimated $211K.
  • Intuitive Surgical made up 0.49% of Trinity Legacy Partners's portfolio in Q2 2026, its #63 holding.
  • Trinity Legacy Partners first reported a position in Intuitive Surgical in Q1 2023 and has held it in 14 quarters since.
  • Trinity Legacy Partners's Intuitive Surgical position peaked at $5.33M in Q2 2023.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.